{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:18Z","timestamp":1761129498506},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"\n Purpose of review<\/jats:title>\n Filamentous fungi respiratory infections, namely because of Aspergillus, Mucorales, Fusarium, or Scedosporium<\/jats:italic>, show rising incidence and occur more in populations which are not classically immunosuppressed. This and their persistent dismal prognosis are the focus of this review.<\/jats:p>\n <\/jats:sec>\n \n Recent findings<\/jats:title>\n Both an early diagnosis, rooted on a high level of suspicion and based on clinical picture, radiology, cultural microbiological exams, fungal biomarkers, PCR and biopsy, and an early therapy, including immunorecovery, whenever possible, good antifungal selection, and surgery for source control, are paramount to maximize the outcome in these diseases. An evolving antifungal armamentarium and a more Pharmacokinetics\/Pharmacodynamics-based antifungal prescription may help to improve the prognosis.<\/jats:p>\n <\/jats:sec>\n \n Summary<\/jats:title>\n Improved awareness of these infections may increase the level of suspicion, promoting early diagnosis and treatment, ideally supported with expert stewardship.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/qco.0000000000000436","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T22:14:48Z","timestamp":1515708888000},"page":"187-193","source":"Crossref","is-referenced-by-count":4,"title":["Aspergillus and other respiratory fungal infections in the ICU: diagnosis and management"],"prefix":"10.1097","volume":"31","author":[{"given":"Jos\u00e9-Artur","family":"Paiva","sequence":"first","affiliation":[{"name":"Intensive Care Medicine Department, Centro Hospitalar S\u00e3o Jo\u00e3o"},{"name":"Faculty of Medicine, University of Porto"},{"name":"Grupo de Infec\u00e7\u00e3o e S\u00e9psis, Porto, Portugal"}]},{"given":"Paulo","family":"Mergulh\u00e3o","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Centro Hospitalar S\u00e3o Jo\u00e3o"},{"name":"Faculty of Medicine, University of Porto"},{"name":"Grupo de Infec\u00e7\u00e3o e S\u00e9psis, Porto, Portugal"}]},{"given":"Jos\u00e9 Manuel","family":"Pereira","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine Department, Centro Hospitalar S\u00e3o Jo\u00e3o"},{"name":"Faculty of Medicine, University of Porto"},{"name":"Grupo de Infec\u00e7\u00e3o e S\u00e9psis, Porto, Portugal"}]}],"member":"276","reference":[{"key":"R1-20230925","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0210-5691(06)74553-3","article-title":"Invasive pulmonary aspergillosis in the nonneutropenic critical patient: future challenges","volume":"30","author":"Olaechea Astigarraga","year":"2006","journal-title":"Med Intensiva"},{"key":"R2-20230925","first-page":"63","article-title":"Invasive pulmonary aspergillosis in critically ill patients","author":"Blot","year":"2013","journal-title":"Annual update in intensive care and emergency medicine"},{"key":"R3-20230925","first-page":"173","article-title":"Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient","volume":"26","author":"Garnacho-Montero","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"R4-20230925","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20230925","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc4823","article-title":"Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients","volume":"10","author":"Vandewoude","year":"2006","journal-title":"Crit Care"},{"key":"R6-20230925","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20230925","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/acb.2004.037","article-title":"Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality","volume":"59","author":"Vandewoude","year":"2004","journal-title":"Acta Clin Belg"},{"key":"R8-20230925","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R9-20230925","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1479972307085637","article-title":"Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature","volume":"5","author":"Samarakoon","year":"2008","journal-title":"Chronic Resp Dis"},{"key":"R10-20230925","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MAJ.0b013e318068d79c","article-title":"Nondecompensated cirrhosis as a risk factor for invasive aspergillosis: a case report and review of the immune dysfunction of cirrhosis","volume":"334","author":"Lipke","year":"2007","journal-title":"Am J Med Sci"},{"key":"R11-20230925","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-7-2","article-title":"Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series","volume":"7","author":"Prodanovic","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"R12-20230925","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1007\/s00134-003-1778-z","article-title":"Immunoparalysis as a cause for invasive aspergillosis?","volume":"29","author":"Hartemink","year":"2003","journal-title":"Intensive Care Med"},{"key":"R13-20230925","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med"},{"key":"R14-20230925","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mmcr.2014.01.003","article-title":"Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review","volume":"4","author":"Parcell","year":"2014","journal-title":"Med Mycol Case Rep"},{"key":"R15-20230925","first-page":"O397","article-title":"Radiological findings in acute invasive pulmonary aspergillosis: utility and reliability of halo sign and air-crescent sign for diagnosis and treatment of invasive pulmonary aspergillosis in high-risk patients","volume":"9","author":"Greene","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"R16-20230925","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1440-1843.2012.02283.x","article-title":"Invasive pulmonary aspergillosis in nonneutropenic patients with and without underlying disease: a single-centre retrospective analysis of 52 subjects","volume":"18","author":"Dai","year":"2013","journal-title":"Respirology"},{"key":"R17-20230925","first-page":"950","article-title":"Fungal infections in ICU patients: epidemiology and the role of diagnostics","volume":"76","author":"Morace","year":"2010","journal-title":"Minerva Anestesiol"},{"key":"R18-20230925","first-page":"1745","article-title":"Algorithms for detection and identification of fungi","author":"Shea","year":"2007","journal-title":"Manual of clinical microbiology"},{"key":"R19-20230925","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/JCM.43.5.2075-2079.2005","article-title":"Workload due to aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital","volume":"43","author":"Bouza","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R20-20230925","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/313918","article-title":"Significance of aspergillemia in patients with cancer: a 10-year study","volume":"31","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R21-20230925","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.amjmed.2011.10.008","article-title":"Invasive mycoses: diagnostic challenges","volume":"125","author":"Ostrosky-Zeichner","year":"2012","journal-title":"Am J Med"},{"key":"R22-20230925","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1586\/eri.12.128","article-title":"Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections","volume":"10","author":"Peman","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R23-20230925","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Resp Crit Care Med"},{"key":"R24-20230925","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1469-0691.2010.03357.x","article-title":"A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1,3)-\u03b2-D-glucan chromogenic assay in serum samples","volume":"17","author":"Acosta","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R25-20230925","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/JLP.JLP_127_16","article-title":"Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnostic of invasive aspergillosis in patients with hematological malignancies","volume":"9","author":"Gupta","year":"2017","journal-title":"J Lab Physicians"},{"key":"R26-20230925","article-title":"Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients","author":"Blimji","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"R27-20230925","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","article-title":"Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study","volume":"49","author":"De Vlieger","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R28-20230925","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcrc.2016.06.026","article-title":"Comparison of 1,3-\u03b2-D Glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients","volume":"36","author":"Lahmer","year":"2016","journal-title":"J Crit Care"},{"key":"R29-20230925","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cmi.2016.06.021","article-title":"Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-\u03b2-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study","volume":"22","author":"Boch","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R30-20230925","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.healun.2017.04.007","article-title":"Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis","volume":"36","author":"Kabbani","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R31-20230925","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jinf.2017.05.014","article-title":"Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies","volume":"75","author":"Orasch","year":"2017","journal-title":"J Infect"},{"key":"R32-20230925","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/cir185","article-title":"Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients","volume":"52","author":"Luong","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R33-20230925","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1473-3099(09)70019-2","article-title":"Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis","volume":"9","author":"Mengoli","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R34-20230925","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JCM.00478-16","article-title":"Detection of Aspergillus fumigatus in blood samples from critically ill patients in Intensive Care units by use of SeptiFast assay","volume":"54","author":"Steinmann","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R35-20230925","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/JCM.01640-16","article-title":"Identification of moulds by matrix-assisted laser desorption ionization-time of flight mass spectometry","volume":"55","author":"Sanguinetti","year":"2017","journal-title":"J Clin MIcrobiol"},{"key":"R36-20230925","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1128\/JCM.01655-16","article-title":"Application of mass spectrometry technology to early diagnosis of invasive fungal infections","volume":"54","author":"Mery","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R37-20230925","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.201407-1275OC","article-title":"Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases","volume":"190","author":"Prattes","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R38-20230925","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/myc.12694","article-title":"Testing the performance of a prototype lateral flow device using bronchoalveolar fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients","volume":"61","author":"Castillo","year":"2018","journal-title":"Mycoses"},{"key":"R39-20230925","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00228-016-2089-y","article-title":"Effect of cytochrome P450 2C19 polymorphisms on the clinical outcomes of voriconazole: a systematic review and meta-analysis","volume":"72","author":"Li","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"R40-20230925","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jac\/dkw045","article-title":"Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis","volume":"71","author":"Jin","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"R41-20230925","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R42-20230925","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10156-013-0607-8","article-title":"Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"19","author":"Hamada","year":"2013","journal-title":"J Infect Chemother"},{"key":"R43-20230925","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13054-015-0758-3","article-title":"Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational defining antibiotic levels in intensive care unit (DALI) patients study","volume":"19","author":"Sinnollareddy","year":"2015","journal-title":"Crit Care"},{"key":"R44-20230925","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, noninferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"R45-20230925","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R46-20230925","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"R47-20230925","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01034-17","article-title":"Exposure-response relationships for isavuconazole in patients with invasive aspergillosis and other filamentous fungi","volume":"61","author":"Desai","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R48-20230925","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/cix297","article-title":"Changes in vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary care cancer center (1999\u20132015)","volume":"65","author":"Heo","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R49-20230925","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/ciu581","article-title":"Antifungal combination therapy for invasive aspergillosis","volume":"59","author":"Mart\u00edn-Pe\u00f1a","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R50-20230925","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"R51-20230925","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R52-20230925","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"R53-20230925","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijantimicag.2017.05.017","article-title":"Drivers and Impact of Antifungal Therapy in Critically Ill Patients with Aspergillus-Positive Respiratory Tract Cultures","volume":"50","author":"Paiva","year":"2017","journal-title":"Int J Antimicrob Ag"},{"key":"R54-20230925","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/cid\/cix198","article-title":"Pharmacodynamics of Isavuconazole for Invasive Mold Disease: role of Galactomannan for Real-Time Monitoring of Therapeutic Response","volume":"64","author":"Kovanda","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R55-20230925","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cmi.2015.12.029","article-title":"Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50 cases in a single centre","volume":"22","author":"Chretien","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R56-20230925","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.amjmed.2011.10.009","article-title":"Invasive mycoses: strategies for effective management","volume":"125","author":"Kontoyiannis","year":"2012","journal-title":"Am J Med"},{"key":"R57-20230925","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cid\/cis195","article-title":"Mucormycosis in organ and stem cell transplant recipients","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R58-20230925","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12879-017-2381-1","article-title":"Mucormycosis in renal transplant recipients: review of 174 reported cases","volume":"17","author":"Song","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R59-20230925","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10\u200amg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R60-20230925","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R61-20230925","doi-asserted-by":"crossref","first-page":"811.e1","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R62-20230925","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2169\/internalmedicine.56.7447","article-title":"The effective treatment of lung infection due to scedosporium prolificans with voriconazole and surgery","volume":"56","author":"Masukane","year":"2017","journal-title":"Intern Med"},{"key":"R63-20230925","doi-asserted-by":"crossref","first-page":"ofv099","DOI":"10.1093\/ofid\/ofv099","article-title":"Invasive fusariosis in the voriconazole era: single-center 13-year experience","volume":"2","author":"Stempel","year":"2015","journal-title":"Open Forum Infect Dis"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001432-201804000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T09:21:52Z","timestamp":1695633712000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201804000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0000000000000436","relation":{},"ISSN":["0951-7375","1473-6527"],"issn-type":[{"value":"0951-7375","type":"print"},{"value":"1473-6527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}